Share on StockTwits

Ekf Diagnostics Holding PLC (LON:EKF)‘s stock had its “buy” rating reiterated by equities researchers at FinnCap in a research report issued on Wednesday. They currently have a GBX 38 ($0.65) price target on the stock. FinnCap’s price target would indicate a potential upside of 47.92% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Analysts at Canaccord Genuity reiterated a “buy” rating on shares of Ekf Diagnostics Holding PLC in a research note on Tuesday, July 8th. They now have a GBX 48 ($0.82) price target on the stock. Separately, analysts at N+1 Singer reiterated a “buy” rating on shares of Ekf Diagnostics Holding PLC in a research note on Wednesday, June 18th. They now have a GBX 38 ($0.65) price target on the stock. Five investment analysts have rated the stock with a buy rating, The stock presently has an average rating of “Buy” and a consensus target price of GBX 40.60 ($0.69).

Ekf Diagnostics Holding PLC (LON:EKF) traded down 3.06% during mid-day trading on Wednesday, hitting GBX 25.69. The stock had a trading volume of 350,353 shares. Ekf Diagnostics Holding PLC has a one year low of GBX 23.60 and a one year high of GBX 43.00. The stock’s 50-day moving average is GBX 26.53 and its 200-day moving average is GBX 31.9.

EKF Diagnostics Holdings Plc designs, develops, manufactures and sells diagnostic instruments, reagents and certain ancillary products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.